Orexo AB´s sustainability work ranked among top 5% by EcoVadis
Orexo AB has achieved a Gold Sustainability Rating from EcoVadis, placing it in the top 5% of the 70,000 businesses reviewed annually. This recognition is based on the company's sustainability efforts in Sweden, covering headquarters functions, R&D, Regulatory Affairs, Quality & SHE, and Supply Chain. The rating highlights Orexo's success in environmental, labor and human rights, ethics, and sustainable procurement areas. CEO Nikolaj Sørensen emphasized that the company will continue to set ambitious sustainability goals to benefit patients, investors, the company, and society.
- None.
- None.
UPPSALA,
This top rating is based on Orexo AB's first year of reporting to EcoVadis and mainly includes sustainability data related to the business in
It showcases the outcome of dedicated sustainability activities undertaken over the last several years across social, environmental and governance areas of Orexo AB. And it shows how the employees and partners are working together to achieve successes across four areas: Environment, Labor and Human Rights, Ethics and Sustainable Procurement.
Nikolaj Sørensen, President and CEO, of Orexo, said, "Achieving this rating is a privilege and we will continue setting ambitious goals in our active pursuit of an even more sustainable and inclusive future for everyone. This is central to our values-based approach to growth and underpins optimal outcomes for patients, investors, the company and society more broadly."
Contacts:
Nikolaj Sørensen, President and CEO
Lena Wange, IR & Communications Director
ir@orexo.com
+46 (0)18 780 88 00
Related links
EcoVadis: https://ecovadis.com/
Sustainability at Orexo: https://orexo.com/sustainability/
About Orexo
Orexo is a Swedish pharmaceutical company with over 25 years of experience developing improved pharmaceuticals based on proprietary formulation technologies that meet large medical needs. On the US market, Orexo provides innovative treatment solutions for patients suffering from opioid use disorder and adjacent diseases. Products targeting other therapeutic areas are developed and commercialized worldwide with leading partners. Total net sales in 2023 amounted to
For more information about Orexo please visit www.orexo.com. You can also follow Orexo on X, LinkedIn, and YouTube.
The information was submitted for publication at 8 a.m. CET, on July 10, 2024.
This information was brought to you by Cision http://news.cision.com
The following files are available for download:
Orexo_PR_Orexo AB sustainability work ranked among top 5 percent by EcoVadis_July 10 2024 | |
4013283_0.png |
View original content:https://www.prnewswire.com/news-releases/orexo-abs-sustainability-work-ranked-among-top-5-by-ecovadis-302193093.html
SOURCE Orexo
FAQ
What sustainability rating did Orexo AB receive from EcoVadis?
What percentage of companies does Orexo AB's EcoVadis rating place it in?
How many businesses are reviewed by EcoVadis annually?
What areas of Orexo AB's operations were included in the EcoVadis sustainability assessment?
What are the key areas highlighted in Orexo AB's EcoVadis sustainability rating?
Who is the CEO of Orexo AB and what did he say about the EcoVadis rating?
How does Orexo AB's sustainability rating benefit its stakeholders?